The spread of the novel coronavirus resulted in the shutdown of much of the developed world. As death tolls and infections rose globally, the race to finding a safe and efficacious vaccine began.
Our approach combined expertise from pharmaceutical and engineering professionals leveraging existing technology. Using linear, covalently closed delivery vectors packaged within decorated bacterial viruses (phages) we developed a system aimed at targetting immune stimulation.
Our Work On A COVID-19 Vaccine
Theraphage’s COVID-19 Response in the News
See the articles and interviews that featured our work, team, and process from Canada and around the globe.
